Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)

Condition:   Acute Lymphoid Leukemia
Intervention:   Procedure: alloHCT
Sponsor:   Asan Medical Center
Terminated - verified May 2016
Source: 
Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)
News Type: 
Clinical Trials